Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity?

Clinical and Experimental Immunology

Volumn 145, Issue 1, 2006, Pages 81-92

  Vitelli Avelar, D M ^a   Sathler Avelar, R ^a,b   Massara, R L ^a   Borges, J D ^c   Lage, P S ^a,b   Lana, M ^c   Teixeira Carvalho, A ^a,c   Dias, J C P ^a   Eloi Santos S M ^a,b   Martins Filho, O A ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

Chagas' disease; Flow cytometry; Peripheral blood; Recent infection

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SUBPOPULATION; CELLULAR IMMUNITY; CHAGAS DISEASE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEART DISEASE; HUMAN; IMMUNOPHENOTYPING; INNATE IMMUNITY; LEUKOCYTE; MACROPHAGE; MALE; MONOCYTE; MORBIDITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD38; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHAGAS DISEASE; CHILD; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MACROPHAGES; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; TRYPANOSOMA CRUZI;

EID: 33745136075     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03123.x     Document Type: Article

References (44)

1. WHO Expert Committee. Control of Chagas' disease. World Health Organ Tech Rep 2002 905 : 1 109.
2. Umezawa ES Stolf AM Corbett CE Shikanai-Yasuda MA. Chagas' disease. Lancet 2000 357 : 797 9.
3. Brener Z Gazzinelli RT. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int Arch Allergy Immunol 1997 114 : 103 10.
4. Marinho CR D'Imperio Lima MR Grisotto MG Alvarez JM. Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease. Infect Immun 1999 67 : 308 18.
5. Sathler-Avelar R Lemos EM Reis DD et al. Phenotypic features of peripheral blood leucocytes during early stages of human infection with Trypanosoma cruzi. Scand J Immunol 2003 58 : 655 63.
6. Vitelli-Avelar DM Sathler-Avelar R Dias JCP et al. Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes. Scand J Immunol 2005 62 : 297 308.
7. Dutra WO Martins-Filho OA Cancado JR et al. Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease. Int Immunol 1994 6 : 499 506.
8. Dutra WO da Luz ZM Cancado JR et al. Influence of parasite presence on the immunologic profile of peripheral blood mononuclear cells from chagasic patients after specific drug therapy. Parasite Immunol 1996 18 : 579 85.
9. Higuchi MD Ries MM Aiello VD et al. Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. Am J Trop Med Hyg 1997 56 : 485 9.
10. Fuenmayor C Higuchi ML Carrasco H et al. Acute Chagas' disease: immunohistochemical characteristics of T cell infiltrate and its relationship with T. cruzi parasitic antigens. Acta Cardiol 2005 60 : 33 7.
11. Gomes JA Bahia-Oliveira LM Rocha MO Martins-Filho OA Gazzinelli G Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun 2003 71 : 1185 93.
12. Souza PE Rocha MO Rocha-Vieira E et al. Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity. Infect Immun 2004 72 : 5283 91.
13. Vitelli DM. Study of immune response of patients carrying different clinical manifestations of Chagas' disease: focus in cellular and molecular aspects of peripheral blood [ Thesis ]. Belo Horizonte: Federal University of Minas Gerais, 2004.
14. Doherty DG Norris S Madrigal-Estebas L et al. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J Immunol 1999 163 : 2314 21.
15. Cooper MA Fehniger TA Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001 22 : 633 40.
16. Cooper MA Fehniger TA Turner SC et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56 (bright) subset. Blood 2001 97 : 3146 51.
17. Baecher-Allan C Brown JA Freeman GJ. Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001 167 : 1245 53.
18. Ziegler-Heitbrock HW. Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. Immunol Today 1996 17 : 424 8.
19. Belge KU Dayyani F Horelt A et al. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 2002 168 : 3536 42.
20. Fragata Filho AA Luquetti AO Prata A et al. Etiological treatment of Chagas' disease (The National Health Foundation of Brazil). Parasitol Today 1997 13 : 127 8.
21. Gaddy J Broxmeyer HE. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells. Cell Immunol 1997 180 : 132 42.
22. Godfrey DI Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 2004 114 : 1379 88.
23. Hontebeyrie-Joskowicz M Minoprio P. Chagas' disease: Trypanosoma cruzi vs. the host immune system. Res Immunol 1991 142 : 125 6.
24. Samudio M Montenegro-James S Cabral M Martinez J. Rojas de Arias A, James MA. Cytokine responses in Trypanosoma cruzi-infected children in Paraguay. Am J Trop Med Hyg 1998 58 : 119 21.
25. Teixeira MM Gazzinelli RT Silva JS et al. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol 2002 18 : 262 5.
26. Bento CA Melo MB Previato JO Mendonca-Previato L Pecanha LM. Glycoinositolphospholipids purified from Trypanosoma cruzi stimulate Ig production in vitro. J Immunol 1996 157 : 4996 5001.
27. Gao W Wortis HH Pereira MA. The Trypanosoma cruzi trans-sialidase is a T cell-independent B cell mitogen and an inducer of non-specific Ig secretion. Int Immunol 2002 14 : 299 308.
28. Acosta-Serrano A Almeida IC Freitas-Junior LH Yoshida N Schenkman S. The mucin-like glycoprotein super-family of Trypanosoma cruzi: structure and biological roles. Mol Biochem Parasitol 2001 114 : 143 50.
29. Argibay PF Di Noia JM Hidalgo A et al. Trypanosoma cruzi surface mucin TcMuc-e2 expressed on higher eukaryotic cells induces human T cell anergy, which is reversible. Glycobiology 2002 12 : 25 32.
30. Dos Reis GA Freire-de-Lima CG Nunes MP Lopes MF. The importance of aberrant T cell responses in Chagas' disease. Trends Parasitol 2005 21 : 237 43.
31. Golgher D Gazzinelli RT. Innate and acquired immunity in the pathogenesis of Chagas' disease. Autoimmunity 2004 37 : 399 409.
32. Aliberti JC Cardoso MA Martins GA Gazzinelli RT Vieira LQ Silva JS. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect Immun 1996 64 : 1961 7.
33. Cardillo F Voltarelli JC Reed SG Silva JS. Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. Infect Immun 1996 64 : 128 34.
34. Blanca IR Bere EW Young HA Ortaldo JR. Human B cell activation by autologous NK cells is regulated by CD40-CD40 ligand interaction. role of memory B cells and CD5+ B cells. J Immunol 2001 167 : 6132 9.
35. Sondergaard SR Ullum H Pedersen BK. Proliferative and cytotoxic capabilities of CD16+CD56- and CD16+/- CD56+ natural killer cells. APMIS 2000 108 : 831 7.
36. Silva JS Vespa GN Cardoso MA Aliberti JC Cunha FQ. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect Immun 1995 63 : 4862 7.
37. Camargo MM Andrade AC Almeida IC Travassos LR Gazzinelli RT. Glycoconjugates isolated from Trypanosoma cruzi but not from Leishmania species membranes trigger nitric oxide synthesis as well as microbicidal activity in IFN-gamma-primed macrophages. J Immunol 1997 159 : 6131 9.
38. Campos MA Almeida IC Takeuchi O et al. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol 2001 167 : 416 23.
39. Michailowsky V Silva NM Rocha CD Vieira LQ Lannes-Vieira J Gazzinelli RT. Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection. Am J Pathol 2001 159 : 1723 33.
40. d'Avila Reis D Lemos EM Silva GC et al. Phenotypic characterization of the inflammatory cells in chagasic mega-oesophagus. Trans R Soc Trop Med Hyg 2001 95 : 177 8.
41. Reis DD Jones EM Tostes S Jr. et al. Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg 1993 48 : 637 44.
42. Wack A Corbella P Harker N Crispe IN Kioussis D. Multiple sites of post-activation CD8+ T cell disposal. Eur J Immunol 1997 27 : 577 83.
43. Murray DA Crispe IN. TNF-alpha controls intrahepatic T cell apoptosis and peripheral T cell numbers. J Immunol 2004 173 : 2402 9.
44. Trzonkowski P Szmit E Mysliwska J Dobyszuk A Mysliwski A. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction. Clin Immunol 2004 112 : 258 67.